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Abstract  
 
Aims: To compare care recipient and caregiver perceptions of quality of life in patients (QoL-
p) with Alzheimer’s disease (AD). To identify associated factors, and the concordances-
discrepancies.  
 
Method: Cross-sectional analytic study of 236 patients and their carers using the Quality of 
Life in Alzheimer’s Disease (QoL-AD) scale, socio-demographic data and clinical 
examination. 
 
Results: Patients scored the QoL-AD more favourably than did caregivers (34.4 vs. 31.3, 
p<0.001). Cognitive deterioration did not affect the perception of QoL-AD (rho= -0.05, 
p=0.394). The neuropsychiatric symptoms was associated with a negative perception of the 
QOL-AD in both patients (rho= -0.22, p<0.01) and caregivers (rho= -0.47, p <0.001). Greater 
functional autonomy was associated with a better perception of the QOL-AD in patients (rho= 
0.17, p<0.01) and even more so in caregivers (rho= 0.56, p<0.001). In carers, burden (rho= -
0.56, p<0.001) and mental health (rho= 0.31, p<0.001) were inversely associated with the 
QoL-AD. QoL-AD scores of both patients and caregivers were higher for men, married 
subjects, those who lived with their spouse and those living in their own home. When the 
carer was a spouse both patients and caregivers scored the QoL-AD higher than when the 
carer was a son or daughter (35.5 vs. 33.4 and 33.7; 32.9 vs. 30.5 and 27.7, p<0,001). 
 
Conclusions: Patients have a better perception of QoL-p. Caregivers give a more negative 
evaluation of neuropsychiatric symptoms, but have a more positive view of functional 
autonomy. Carers who are spouses have a better perception of QoL-p than do carers who are 
sons or daughters. 
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Introduction  
 
Alzheimer’s disease (AD) is a significant public health concern due to its high prevalence, the 
serious consequences for patients, and the burden it places on families (Garre-Olmo et al., 
2000). Given the enormous costs to the individual and the family that derive from the 
chronicity and severity of the disease one of the key objectives of the services offered to 
patients and their relatives is therefore to maintain quality of life.  
The concept of and emphasis placed on the quality of life of patients (QoL-p) with dementia 
has emerged particularly over the last decade (Whitehouse et al., 2003; Lucas-Carrasco, 
2007), and evaluation of this aspect has been progressively included as part of clinical 
guidelines for treating dementia patients. Since 2001 the Group for Harmonization of 
Dementia Drug Guidelines and the Alzheimer’s Society (Mack and Whitehouse, 2001) have 
recommended the evaluation of quality of life to verify the efficacy and appropriateness of 
therapeutic interventions, not only from the patient’s perspective but also from that of family 
caregivers or professionals. However, research is still needed to clarify a number of key 
questions: which measures are the most valid and reliable for assessing QoL-p, what is the 
best type of administration (auto or rater-administrated questionnaire) according to the degree 
of cognitive impairment, who are the best informants, and which factors influence the 
perception of QoL-p in patients and other informants (Naglie, 2007). 
The aims of the present study were, firstly, to compare the perceptions of patients and family 
caregivers of QoL-p in AD; secondly, to identify the socio-demographic and clinical factors 
associated with the care recipient and caregiver perception of QoL-p; and thirdly, to identify 
the points of agreement and disagreement between patients and carers as regards QoL-p.  
 
 
Method 
 
Study population 
 
The sample comprised 236 patients diagnosed with AD according to DSM-IV (APA, 2001) 
criteria and probable AD according to NINCDS-ADRDA (McKhann et al., 1984) criteria, 
along with their corresponding family caregivers. The main carer was defined as the person 
who was responsible for helping the patient with daily living activities, both basic (self-care 
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such as bathing, dressing and undressing, etc.) and instrumental (personal autonomy such as 
using the telephone or managing money), as well as for supervising him or her at home. 
All the AD subjects were seen as out-patients in the Memory and Dementia Assessment Unit 
of the Santa Caterina Hospital in Girona (Spain) and formed part of the SIDEA research 
project (Seguimiento Integral de la Enfermedad de Alzheimer - Comprehensive Follow-Up of 
Alzheimer’s Disease). This is a four year observational, longitudinal and pragmatic cohort 
study. Using a standardized protocol it aims to describe and follow-up a large cohort of 
patients diagnosed with Alzheimer’s disease, as well as their family caregivers, who receive 
outpatient medical and social care at secondary-level centres in our area. The study was 
approved by the Ethics Committee for Clinical Research of the local health authority. All the 
patients and their carers gave their written consent to participate in the study. The data 
analysed corresponded to the baseline assessment session of the SIDEA study. 
 
Procedure 
 
In the initial interview the aims of the study were explained to patients and caregivers, who 
were then interviewed separately. The assessment instruments were administered by a clinical 
neuropsychology research team from the hospital.  
 
Study protocol  
 
Measuring quality of life  
The Quality of Life in Alzheimer’s Disease (QoL-AD) scale was administered to patients and 
caregivers in order to assess their perception of QoL-p. The scale consists of thirteen items 
that reflect the subject’s perception of different aspects related to wellbeing: physical health, 
energy, mood, living situation, memory, family, marriage, friends, self as a whole, ability to 
do chores around the house, ability to do things for fun, money, and life as a whole. Possible 
scores range from 13 to 52 (Logsdon et al., 1999; 2002).  
 
Instruments for examining socio-demographic and clinical variables  
The socio-demographic characteristics of the patient and caregiver (age, gender, marital 
status, level of education, place of residence, family relationship, whether they lived together, 
employment situation, other family burdens such as children or disabled people care) were 
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recorded by means of a structured interview, the Cambridge Mental Disorders of the Elderly 
Examination (CAMDEX-R, Sections A and H ) (Roth et al., 1986). 
The clinical examination of the patient was conducted using the following instruments: 
- Cambridge Cognitive Examination-Revised (CAMCOG-R). This forms part of the 
CAMDEX and assesses various cognitive functions, with possible scores ranging from 0 to 
107, with the cut-off point for the Spanish population being 68/69 (Vilalta-Franch et al., 
1990). 
- Mini Mental State Examination (MMSE). A brief cognitive examination whose scores 
range from 0 to 30, the cut-off point for cognitive impairment being 21/22 (Folstein et al., 
1975). This was used to evaluate the severity of cognitive impairment (Kraemer et al., 
1998).  
- Disability Assessment for Dementia (DAD). This scale assesses a wide range of daily living 
activities (ADL): basic, instrumental and leisure. It comprises 40 items and scores range 
from 0-100. (Gélinas et al., 1999; Feldman et al., 2001). 
- Neuropsychiatric Inventory (NPI). This instrument for evaluating psychiatric 
symptomatology in AD is administered to the carer. It comprises twelve subscales and score 
ranges from 0 to 144. (Cummings et al., 1994; Vilalta-Franch et al., 1999). 
The clinical examination of the carer was conducted using the following instruments:  
- SF-12 Health Survey (SF-12v1) Short form of the SF-36 Health Survey. It comprises twelve 
items and scores range from 12 to 47. Two global dimensions can be obtained from the 
direct scores: physical health and mental health, and in both dimensions the score ranges 
from 0 to 100 (Ware et al., 1996; Alonso et al., 1998).  
- Caregiver Burden Interview (CBI). A questionnaire designed to assess the burden 
experienced by carers. It comprises 22 items and scores range from 0 to 88 (Zarit et al., 
1986; Martín et al., 1996). 
 
Statistical analysis 
A descriptive analysis of the data was conducted and differences in means for the QoL-AD 
scale were calculated using the non-parametric Wilcoxon signed-rank test. The degree of 
correlation and concordance between the scores of patients and caregivers on the QoL-AD 
were also analysed by means of Spearman’s rank correlation coefficient and the Kappa index, 
respectively.  
The analysis of relationships between the scores of patients and caregivers on the QoL-AD 
and the socio-demographic and clinical factors of patients and caregivers was conducted using 
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the non-parametric Mann-Whitney U and Kruskal-Wallis tests. The correlations used were 
Pearson’s for continuous variables and Spearman’s for discontinuous variables. 
When the comparison of two means revealed significant differences Cohen’s d was used as a 
measure of effect size.  
In order to determine the overall effect of the clinical and socio-demographic variables on the 
perception of QoL-p in patients and caregivers, two multivariate linear regression analyses 
were carried out. The dependent variables were scores on the QoL-AD of the patient and 
caregiver, while the independent variables were those found to be significant in the bivariate 
analysis.  
Statistical significance was set at 0.05 in order to compare hypotheses.  
 
 
Results 
 
Description of the sample  
The mean age of patients was 77.8 (s.d. = 6.9) and that of caregivers 59.9 (s.d. = 14.6). Of the 
patient group 79 were men (33.5%) and 157 women (66.5%), while caregivers were 70 men 
(29.7%) and 166 women (70.3%). As regards the family relationship, 103 (43.6%) caregivers 
were the patient’s spouse and 109 (46.2%) were the son or daughter. The number of 
caregivers who lived with the patient was 153 (64.8%), while 83 (35.2%) supervised the care 
of but did not live with the patient (Table 1). 
 
Clinical data 
The mean score of patients on the CAMCOG was 56.0 (s.d. = 11.6). Seventy-six patients 
(32.2%) patients had mild cognitive impairment (MMSE >20), 154 (65.3%) showed moderate 
cognitive impairment (MMSE = 11-20), and 6 (2.5%) had severe cognitive impairment 
(MMSE <11). The mean DAD score was 85.4 (s.d. = 8.0) and the mean total score on the NPI 
was 10.6 (s.d. = 12.2).  
The clinical questionnaires administered to caregivers revealed a mean score on the SF-12 of 
46.7 (s.d. = 10.9) and 49.4 (s.d. = 9.3) for the mental and physical health dimensions, 
respectively. The mean score on the CBI was 40.7 (s.d. = 12.3) (Table 2).  
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Perception of QoL-p in patients and caregivers  
The item “marriage” from the QoL-AD scale was only applied to patients and caregivers 
when the patients had a spouse (n = 148) at the time of the interview; for each of the 
remaining subjects (n = 88) the scores for this item were weighted according to the total scale 
score.  
The total mean score of the QoL-AD scale showed that patients (mean = 34.4; s.d. = 4.6) and 
caregivers (mean = 31.3; s.d. = 5.2) had a different subjective perception of QoL-p, this 
difference being significant (z = -7.462; p<0.001; d = 0.628) with a medium/high effect size. 
Patients also scored significantly higher on all items except living situation. Particularly 
noteworthy among these differences was that for memory (z = -6.479; p<0.001; d = 0.642) 
(Table 3).  
 
Patient factors associated with the perception of QoL-p in patients and caregivers 
The analysis of associations between the socio-demographic data of patients and QoL-AD 
scores (Table 4) revealed, for patients, higher perceived QoL-p for men (p<0.001; d = 0.612), 
those who were married, who lived with their spouse and those who lived in their own home. 
The data for caregivers showed agreement on all these aspects: men, those who were married, 
who lived with their spouse (p<0.001; d = 0.812) and those who lived in their own home; an 
additional factor here was younger age.  
There were no significant differences in the QoL-AD score according the educational groups, 
neither among patients nor caregivers. 
The most relevant clinical factor was depression, as lower scores for QoL-p were given by 
patients who scored high on NPI-depression (p<0.001). Smaller but still significant 
correlations were also observed for NPI-apathy, NPI-total score and greater autonomy on the 
DAD (p<0.01).  
In caregivers the significant correlations with clinical data were more diverse. The DAD, 
NPI-apathy, NPI-total, NPI-depression and NPI-appetite all showed greater significant 
correlations (p<0.001), as did, with a smaller effect, NPI-agitation, NPI-anxiety and NPI-
elation (p<0.01). 
No significant correlations were observed, for either patients or caregivers, between QoL-AD 
scores and cognitive tests. 
As regards gender, patients and caregivers agreed in perceiving that men had better QoL-p. 
Examination of the clinical data of patients showed that the only significant differences 
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related to gender concerned depression and anxiety, with higher scores for women: NPI-
depression (z = -2.572; p<0.01) and NPI-anxiety (z = -3.696; p<0.001; d =-0.512). 
 
 
Caregiver factors associated with the perception of QoL-p in patients and caregivers 
Comparison of the socio-demographic data for caregivers with QoL-AD scores (Table 5) 
revealed that both patients (p<0.001) and caregivers (p<0.01) perceived better QoL-p when 
the caregiver was older.  
Patients and caregivers agreed in scoring higher QoL-p when the caregiver was a spouse 
without other family burdens, who was the sole carer and who lived with the patient. 
No significant differences were found as regards gender, years of education, marital status or 
the employment situation of caregivers.  
In terms of clinical factors, caregivers with a higher correlation on the mental health 
dimension (rho = 0.311; p<0.001) perceived better QoL-p, while those with high levels of 
burden perceived worse QoL-p (rho = 0.562; p<0.001).  
 
Spouse caregivers and son/daughter caregivers in relation to QoL-p  
Son/daughter caregiver scores (mean = 30.5; s.d. = 5.3) on the QoL-AD were significantly 
lower than those of spouse caregivers (mean = 32.9; s.d. = 4.4); (z = -3.272; p<0.01; d = 
0.477). A similarly significant difference was also observed in the QoL-AD of patients with 
son/daughter caregivers (mean = 33.4; s.d. = 4.6) compared to those who were cared for by a 
spouse (mean = 35.5, s.d. = 4.2); (z = -3.366; p<0.01; d = 0.418).  
The level of burden of son/daughter caregivers (CBI = 42.4; s.d. =12.7) was greater than that 
of spouse caregivers (CBI = 37.7; s.d. = 10.2), this difference being significant (z = -2.723; 
p<0.01; d = 0.414). The correlation between caregiver burden and the QoL-AD was 
significant for the two groups (p<0.001), although the value was higher in the case of 
sons/daughters (son/daughter caregivers, rho = -0.636; spouse caregivers, rho = -0.508). 
As regards physical health, spouse caregivers (SF-12 = 45.9; s.d. = 9.7) suffered the effects 
more than did son/daughter caregivers (SF-12 = 52.5; s.d. = 8.1), this difference being highly 
significant (z = -5.177; p<0.001; d = 0.715); however, there was no significant correlation 
with the QoL-AD score of patients and caregivers.  
With respect to the mental health dimension, spouse caregivers had better health (SF-12 = 
48.4; s.d. = 9.1) than son/daughter caregivers (SF-12 = 44.3; s.d. = 12.6), this difference being 
less significant (z = -2.005; p<0.05); however, the correlation between mental health and the 
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QoL-AD was only significant and in a positive direction (the better the mental health, the 
higher the QoL-p score) for son/daughter caregivers (rho = 0.428; p<0.001). 
 
Multivariate linear regression analysis 
The linear regression analysis (Table 6) revealed that the QoL-AD patient score predictors 
were, in patients, depression (p<0.001), gender (p<0.01) and the DAD score (p<0.05); in 
caregivers the predictors were the DAD score (p<0.001), apathy (p<0.001) and depression 
(p<0.01). The coefficient of determination of the multivariate model was 0,298. The QoL-AD 
caregiver score predictors were, in patients, age and caregiver burden (p<0.05); in caregivers 
the predictors were burden (p<0.001), mental health and family relationship (p<0.05). The 
coefficient of determination of the multivariate model was 0,522. 
 
 
Discussion 
 
Differences in the perception of QoL-p 
Concordance between the two QoL-AD scores, measured by means of the Kappa index, was 
low for all items, as only correlations above 0.4 can be considered clinically significant. This 
differing perception of patients and caregivers, with better scores among patients, is similar to 
that reported by other studies (Thorgrimsen et al., 2003; Sands et al., 2004; Ready et al., 
2006). In addition, and in line with previous research (Hoe et al., 2005; Vogel et al., 2006), 
the perception of QoL-p was not correlated in either patients or caregivers with levels of 
cognitive impairment; indeed, the better scores among patients were preserved, with a similar 
difference between patients and caregivers for all levels of impairment. Studies that compared 
the perception of patients with that of the professionals caring for them also report better 
QoL-p scores among patients (Cheon et al., 2005; Hoe et al., 2006).  
In global terms there appear to be two independent and distinct points of view (Ready et al. 
2006), in which the disease situation seems to affect caregivers more than patients 
themselves. In this regard, it should be noted that studies of subjective wellbeing in dementia 
(Livingston et al., 2008) and in normal ageing (Mroczek and Kolarz, 1998) also report this 
paradox, namely the presence of high levels of well-being in the face of objective difficulties 
or contextual or socio-demographic risk factors that intuitively would be expected to cause 
unhappiness.  
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Clinical factors 
Neuropsychiatric symptoms in the patient (depression and apathy) were associated with lower 
perceived QoL-p in both the patient and caregiver groups. Among the neuropsychiatric 
symptoms associated with lower QoL-p, relatives included those that imply heightened motor 
activity (agitation, anxiety, elation and aberrant motor behaviour) and which placed an 
increased burden on the caregiver.  
The correlation between the degree of autonomy for ADL and the QoL-AD was significant 
for both patients and caregivers, although it was of greater relevance for the latter. From the 
caregivers’ perspective, reduced autonomy implied a greater global impairment in the patient, 
and therefore greater burden for the caregiver.  
Among caregivers the degree of burden and mental health were inversely associated with 
perceived QoL-p: a greater burden was linked to lower perceived QoL-p while a higher score 
on the mental health dimension was associated with a higher score for perceived QoL-p. 
The linear regression analysis revealed that the most important predictors were depression, for 
patients, and autonomy in ADL, apathy and caregiver burden for carers. In line with several 
previous studies depression in the patient was the main clinical factor associated with lower 
perceived QoL-p in patients themselves (Sands et al., 2004; Cheon et al., 2005; Selwood et 
al., 2005; Vogel et al., 2006; Hoe et al., 2006; Fuh and Wang, 2006; Hoe et al., 2007). In 
caregivers the main clinical factors associated with lower perceived QoL-p were caregiver 
burden (Thorgrimsen et al., 2003; Sands et al., 2004), autonomy for ADL (Cheon et al., 2005; 
Hoe et al., 2006; Hoe et al., 2007) and apathy (Hoe et al., 2007). In fact, these three aspects 
could be considered to be related: depressive symptoms increase functional disability (ADL), 
are associated with an increased presence of non-cognitive symptoms and, overall, increase 
caregiver burden (Garre-Olmo et al., 2002). 
Despite the differences indicated between patients and caregivers, however, it should be noted 
that some studies which compared the perceptions of patients and professionals reported even 
greater discrepancies, both qualitatively and quantitatively, among the factors associated with 
QoL-p. Whereas the predominant factors among patients were depression and anxiety, 
professionals cited the increasing problems of dependency and behaviour (Hoe et al., 2006).  
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Socio-demographic factors 
The analysis of the socio-demographic factors that affect patient and caregiver perceptions of 
QoL-p according to the QoL-AD scale proved to be a more complex and novel task. Two 
aspects need to be highlighted here. 
Gender of the patient: Patients and caregivers agreed in perceiving better QoL-p in patients 
who were men. The results indicate that women had higher levels of depression and anxiety, 
as occurs in the general population (Regier et al., 1993; Copeland et al., 1999).This finding is 
consistent with what is observed in clinical practice when offering support to relatives of 
patients with Alzheimer’s disease, and could also be related to the greater difficulties women 
face in terms of continuing to perform the tasks associated with their role in the family and 
generational context (Conde-Sala, 2006). 
Relationship of the caregiver to the patient: The data show that caregivers had a more positive 
perception of QoL-p when patients were married, lived with their spouse or lived in their own 
home. At the same time, older caregivers, those who were the patient’s spouse, who lived 
with him/her, were the sole carer and who had no other family burdens scored higher for QoL 
-p. These results suggest that two clearly distinct subgroups could be defined within the group 
of family caregivers: spouse caregivers and son/daughter caregivers. In this regard, 
son/daughter caregivers scored lower for perceived QoL-p than did spouse caregivers. This 
difference was also observed among patients: those who were cared for by a son or daughter 
scored lower for perceived QoL-p than did those who were looked after by a spouse.  
Given the results obtained it would not seem that this difference can be explained by any 
especially relevant or differential clinical factor linked to patients. Furthermore, the only 
clinical factor for caregivers of relevance here would be burden, which was high in both sub-
groups, although more so in the group of son/daughter caregivers. 
One explanation for these differences could be the nature of the family relationship between 
patient and caregiver and the factors associated with this. Spouse caregivers would be closer 
to the patient in many aspects of life such as age, the fact of living together, and family and 
generational factors, and in this context the task of caring for the patient would occupy a 
sizeable proportion of their life together, thus generating greater empathy between them. In 
contrast, for son/daughter caregivers the abovementioned aspects of life would not only be 
more distant but may clash with other obligations: work, their own children, etc.  
The analysis of socio-demographic data thus suggests that when it comes to perceived QoL-p, 
caregivers should not be treated as a uniform group; rather, the family relationship variable 
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(spouse vs. son/daughter) should be introduced in order to observe the behaviour of the two 
sub-groups with respect to clinical and socio-demographic data. 
 
Clinical implications 
The results of the present study, especially those obtained in the multivariate linear regression 
analysis, support the importance of treating depression in patients with Alzheimer’s disease; 
depression is not only associated with other neuropsychiatric (NPI) and functional (ADL) 
symptoms (Garre-Olmo et al., 2003), but also has repercussions for the quality of life of both 
patients and their relatives (López-Pousa et al., 2007). 
As regards caregivers it is important to address aspects related to burden and mental health. 
Information about the disease, the provision of healthcare resources, and social and emotional 
support are clearly necessary to reduce caregiver burden, which not only affects carers but 
also, in an indirect way, patients (Conde-Sala, 2006). Thus, the mental health needs of 
caregivers must be taken into account and evaluated, as this aspect affects the perception of 
QoL-p, especially when the carer is a son or daughter. 
The distinction between spouse and son/daughter caregivers has implications for the approach 
of professionals in alleviating the symptoms of caregiver burden; indeed, the different 
position in the relationship and social/family situation generates different behaviours and 
perceptions as regards QoL-p depending on whether the caregiver is the spouse or 
son/daughter of the patient. 
 
Limitations 
As already indicated, analysing caregivers as a uniform group may undermine some of the 
results, and it would be advisable to distinguish between spouse and son/daughter caregivers 
and the relationship between these two sub-groups and perceived QoL-p for all the data; 
further studies are thus required in order to consider these differences in greater detail. 
The data from participants correspond to the baseline interview of the study. It would 
therefore be useful to observe the evolution in perceived QoL-p in both patients and 
caregivers in a subsequent longitudinal study.  
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 Table 1. Socio-demographic factors of participants  
 
 
 Patients (n = 236) Caregivers (n = 236) 
  
 Age, years      Age, years  
  Mean (s.d.)  77.8 (6.9)  Mean (s.d.)  59.9 (14.6) 
  Range   55-93  Range    27-87 
 Gender      Gender 
  Female, n (%) 157  (66.5)  Female, n (%) 166  (70.3) 
 Marital status, n (%)      Marital status, n (%) 
  Married                          148  (62.7)  Married  204  (86.5) 
  Widowed  80  (33.9)     Widowed    8    (3.4) 
  Single    8    (3.4)    Single   15     (6.4) 
  Divorced  -- ---     Divorced    9     (3.8) 
 Level of education, n (%)      Level of education, n (%) 
  Illiterate, no schooling   53 (22.5)  Illiterate, no schooling   30 (12.7) 
  < 8 years  159 (67.4)    < 8 years   83 (35.2) 
  > 8 years   24 (10.2)   > 8 years  120 (50.8) 
    
 
 Living situation, n (%)       Family relationship of caregiver, n (%) 
  With spouse 120 (50.8)  Spouse 103 (43.6) 
  With relative   39 (16.5)  Son/daughter 109 (46.2) 
  Alone  34 (14.4)  Other relative  23  (9.7) 
 Residence, n (%)        Living with patient, n (%) 
  Own home 193  (81.8)  Yes 153 (64.8) 
  Relative’s home    42  (17.8) Sole carer, n (%) 
         Yes 137 (58.1) 
        Other family burdens, n (%) 
         Yes   87 (36.9) 
        Employment situation, n (%) 
         In work 101 (43.3)  
         Retired  98 (42.1) 
         Housewife  26 (11.2) 
         Unemployed   8  (3.4) 
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 Table 2. Clinical factors of participants  
 
 Patients  n Mean  s.d. Range 
 
 DAD   236 85.4   8.0 52.50-100 
  
 NPI  236 
 A  Delusions     0.3  1.3  0-12 
 B  Hallucinations     0.1  1.0  0-08 
 C  Agitation     1.0  2.2  0-12 
 D Depression     1.6  2.7  0-12 
 E Anxiety    0.8  1.8  0-12 
 F Elation     0.05  0.4  0-03 
 G Apathy     2.5  3.0  0-12 
 H Disinhibition    0.3  1.0  0-06 
 I Irritability    1.3  2.2  0-12 
 J Aberrant motor behaviour  0.4  1.4  0-08 
 K Sleep disorders     0.9  2.2  0-12 
 L Appetite     1.0  2.3  0-12 
 TOTAL   10.6   12.2  0-96 
  
 CAMCOG-R  236 56.0 11.6 29-86 
  
 MMSE levels, n (%)  236 
  Mild > 20     76 (32.2)      
  Moderate  11-20              154 (65.3) 
 Severe < 11       6 (  2.5)  
  
 
 Caregivers    Mean  s.d. Range 
 
 SF-12 
  Mental component   234  46.7 10.9 15.30-65.70 
  Physical component   234  49.4   9.3 21.01-67.01 
  
 CBI Zarit  236  40.6 12.3 22-82 
 
 
DAD: Disability Assessment for Dementia; NPI: Neuropsychiatric Inventory; CAMCOG-R:  
Cambridge Cognitive Examination-Revised; MMSE: Mini Mental State Examination 
SF-12: Short Form of Health Survey; CBI: Caregiver Burden Interview  
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 Table 3. Patient’s quality of life according to the QoL-AD score of patients and caregivers  
 
 
 QoL-AD  Patients  Caregivers Wilcoxon Cohen’s d Spearman coeff.  Kappa 
  n = 236 Mean s.d. Mean s.d. z p  rho p  k  
 
 Physical health   2.6 0.6  2.5 0.7 -2.127 0.033 0.169 0.297 0.000 0.229
 Energy   2.5 0.7  2.3 0.7 -3.646 0.000 0.300 0.287 0.000 0.191
 Mood   2.4 0.7  2.1 0.7 -5.925 0.000 0.420 0.316 0.000 0.175
 Living situation   2.8 0.5  2.7 0.6 -0.229 0.819 0.018 0.093 0.153 0.066
 Memory   2.0 0.6  1.6 0.5 -6.479 0.000 0.642 0.055 0.401 0.080
 Family   3.2 0.5  3.0 0.6 -5.109 0.000 0.467 0.134 0.040 0.059
 Marriage         (n = 148)  3.2 0.6  2.9 0.6 -4.740 0.000 0.496 0.225 0.006 0.171
 Friends   3.0 0.6  2.6 0.8 -5.348 0.000 0.447 0.265 0.000 0.169
 Self as a whole   2.7 0.5  2.5 0.6 -5.685 0.000 0.491 0.264 0.000 0.223
 Ability to do chores  2.6 0.6  2.2 0.7 -5.385 0.000 0.451 0.301 0.000 0.214
 Ability to do things for fun  2.3 0.7  2.0 0.8 -4.737 0.000 0.398 0.293 0.000 0.180
 Money   2.8 0.5  2.6 0.6 -2.990 0.003 0.247 0.142 0.030 0.100
 Life as a whole   2.7 0.5  2.6 0.6 -3.510 0.000 0.298 0.255 0.000 0.194
 Total score  34.4 4.6     31.3 5.2 -7.462 0.000 0.628 0.360 0.000 .........  
  
  
    QoL-AD: Quality of Life in Alzheimer's Disease  
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 Table 4. Patient factors and relationships with the QoL-AD scale for patients and caregivers  
 
   QoL-AD patients QoL-AD caregivers   
 Patient factors  n Mean s.d. p Cohen’s d Mean s.d. p Cohen’s d 
 
 Age 1  236 77.8 6.9 r  =  0.125  77.8 6.9 r  =  -0.176   
      p  =  0.054   p  =   0.007** 
 Gender 2   
  Male    79 36.1 3.7 z  =  -4.042  32.6 5.1 z  =  -2.912   
 Female    157 33.5 4.7 p  =  0.000*** 0.612 30.7 5.2 p  =   0.004** 0.363 
 Education 3    
  Illiterate, no sch.  53 33.5 4.9 χ2 =  3.636  31.6 4.9 χ2 =   1.261   
 < 8 years  159 34.5 4.4 p  =  0.162  31.1 5.3 p  =   0.532 
 > 9 years    24 35.5 4.7     32.4 5.2 
 Marital status 3   
  Married  148 35.1 4.4 χ2 =  12.973  32.3 4.9 χ2 =  15.053  
  Widowed   80 33.2 4.4 p  =  0.002** 0.422 29.7 5.3 p  = 0.001** 0.526 
  Single    8 32.6 6.1     28.8 6.8 
 Living situation 3 
  With spouse  120 35.0 4.4 χ2 =  8.395  32.9 4.9 χ2 =  20.472  
  With relative   39 33.0 4.8 p  =  0.015* 0.447 28.5 5.3 p  =  0.000*** 0.862 
  Alone   34 34.0 4.2     30.7 5.6 
 Residence 2  
  Own home   193 34.8 4.4 z  =   2.838  31.8 5.1 z  =  2.697   
  Relative’s home  42 32.6 4.8 p =   0.005** 0.475 29.2 5.4 p  =  0.007** 0.489 
 
 MMSE levels3 
  Mild > 20   76 34.1 4.5 χ2 = 1.777 30.1 5.3 χ2 =  0.821  
  Moderate  11-20  154 34.7 5.6 p = 0.411 30.6 5.5 p  =  0.663 
 Severe < 11    6 33.0 6.8    30.1 2.9  
  
     rho p rho p 
 DAD 4 236   0.179 0.006**  0.565 0.000*** 
 NPI  236  
  A  Delusions   -0.017 0.793 -0.076 0.247 
  B  Hallucinations    -0.001 0.982 -0.046 0.482 
  C  Agitation     0.085 0.193 -0.195 0.003** 
  D Depression   -0.289 0.000*** -0.318 0.000*** 
  E Anxiety   -0.145 0.026* -0.188 0.004** 
  F Elation   -0.058 0.373 -0.170 0.009** 
  G Apathy   -0.204 0.002** -0.504 0.000*** 
  H Disinhibition   -0.026 0.687 -0.123 0.059 
  I Irritability     0.082 0.212 -0.122 0.062 
  J Aber. motor beh.  -0.065 0.321 -0.133 0.041* 
  K Sleep disorders   -0.064 0.330 -0.082 0.209 
  L Appetite   -0.144 0.027* -0.250 0.000*** 
  Total    -0.223 0.001** -0.472 0.000*** 
 CAMGOC-R 236  -0.056 0.394   0.097 0.139 
       
 
* p<0.05; ** p<0.01; ***p<0.001. 1 Pearson’s coeff;  2 Mann-Whitney U; 3 Kruskal-Wallis; 4 Spearman’s coeff. 
 
QoL-AD: Quality of Life in Alzheimer's Disease; MMSE: Mini Mental State Examination; DAD: Disability Assessment for Dementia; NPI: Neuropsychiatric 
Inventory; CAMCOG-R: Cambridge Cognitive Examination-Revised. 
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 Table 5. Caregiver factors and relationships with the QoL-AD scale for patients and caregivers  
 
 QoL-AD patients QoL-AD caregivers   
 Caregiver factors  n Mean s.d. p Cohen's d Mean s.d. p Cohen's d 
  
 Age 1 236 59.9 14.6 r  = 0.230  59.9 14.6 r = 0.174  
        p = 0.000***    p = 0.009** 
 Gender 2    
  Male   70 33.7 4.8 z = -1.246  31.1 5.4 z = -0.470  
  Female   166 34.7 4.4 p = 0.213  31.4 5.2 p = 0.638 
 Education 3    
  Illiterate, no sch.  30 34.6 3.6 χ2 = 0.094  30.3 4.8 χ2 = 4.162  
  < 8 years  83 34.4 4.7 p = 0.954  32.1 4.9 p = 0.125 
  > 9 years  120 34.8 4.7     31.0 5.5 
 Marital status 3   
  Single  15 33.3 5.3 χ2 = 2.137  29.4 4.1 χ2 = 4.896   
  Married 204 34.6 4.4 p = 0.544  31.6 5.3 p = 0.180 
  Widowed   8 32.0 6.2     29.9 6.0 
  Divorced   9 34.7 4.9     29.5 5.1 
 Family relationship 3  
  Spouse 103 35.5 4.2 χ2 =  11.870  32.9 4.4 χ2 = 21.143   
 Son/daughter 109 33.5 4.6 p = 0.003**  0.463 30.5 5.4 p = 0.000**  0.477 
  Other relative   23 33.7 4.8     27.7 5.5 
 Living with patient 2 
  Yes 153 34.8 4.5 z =  2.060  31.9 5.1 z =  2.424   
 No  83 33.6 4.6 p = 0.039*  0.275 30.3 5.3 p = 0.015*  0.308 
 Sole caregiver 2   
  Yes 137 35.1 4.4 z =  2.977  32.3 4.9 z =  3.416  
  No  98 33.3 4.5 p = 0.003**  0.398 29.9 5.4 p = 0.001**  0.470 
 Other family burdens 2  
  Yes  87 33.4 4.9 z = -2.372  30.4 5.5 z = -2.206   
 No 149 35.0 4.3 p = 0.018* -0.340 31.9 5.0 p = 0.027* -0.286 
 Employment situation 3   
  Retired  98 35.2 4.5 χ2 = 6.919  32.2 4.8 χ2 = 4.804  
  In work 101 33.7 4.5 p = 0.075  31.0 5.3 p = 0.187 
  Domestic work  26 34.7 4.4     29.7 5.8 
  Unemployed   8 33.0 5.6     30.1 6.4 
   
   
      rho p     rho p 
 SF-12 4 234 
  SF-12 Physical    -0.092 0.162     -0.059 0.371 
  SF-12 Mental      0.110 0.094      0.311 0.000*** 
 CBI. Zarit  236 -0.149 0.022*     -0.562 0.000*** 
       
  
 * p<0.05; ** p<0.01; ***p<0.001.  1 Pearson’s coeff;  2 Mann-Whitney U; 3 Kruskal-Wallis; 4 Spearman’s coeff.  
 
 QoL-AD: Quality of Life in Alzheimer's Disease; SF-12: Short Form of Health Survey; CBI: Caregiver Burden Interview.  
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Table 6. Multivariate linear regression analysis 
  
 Patient factors a QoL-AD patients  QoL-AD caregivers    
 Beta p Beta p
   
 Gender -0.232 0.001** -0.098 0.077 
  
 DAD  0.164 0.023*  0.393 0.000*** 
 NPI D Depression -0.278 0.000***  -0.170 0.003** 
 NPI G  Apathy  -0.049 0.502 -0.227 0.000*** 
  
   
 Caregiver factors b QoL-AD patients QoL-AD caregivers  
  Beta p Beta p 
 
 Age  0.198 0.039* -0.149 0.074 
 Relationship  0.019 0.841 -0.204 0.013* 
  
 SF-12 Mental  ........ .........  0.143 0.024*   
 CBI Zarit -0.135 0.049* -0.452 0.000*** 
 
 
a r2=0,298; b r2=0,522 
* p<0.05; ** p<0.01; ***p<0.001 
 
Adjusted for:  
-  Non-significant patient factors: Age, Marital status, Living situation, Residence, NPI-Agitation,  
 NPI-Anxiety, NPI-Elation, NPI-Aber. motor beh., NPI-Appetite. 
-  Non-significant caregiver factors: Living with patient, Sole carer, Other family burden  
 
QoL-AD: Quality of Life in Alzheimer's Disease; DAD: Disability Assessment for Dementia; NPI:  
Neuropsychiatric Inventory; SF-12: Short Form of Health Survey; CBI: Caregiver Burden Interview 
 
 
 
